Evidence map›Paper›PMID 27824626›Full record

ArticleAIDS (London, England)2016

Reducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjects.

Tetyana I Vasylyeva, Samuel R Friedman, Jose Lourenco, Sunetra Gupta, Angelos Hatzakis, Oliver G Pybus, Aris Katzourakis, Pavlo Smyrnov, Timokratis Karamitros, Dimitrios Paraskevis and 1 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in AIDS (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Molecular epidemiology reveals the role of war in the spread of HIV in Ukraine.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Tetyana I VasylyevaaDepartment of Zoology, University of Oxford, Oxford, United Kingdom bNational Development and Research Institutes, Inc, New York, New York, USA cDepartment of Hygiene, Epidemiology, and Medical Statistics, Athens University Medical School, Athens, Greece dInternational HIV/AIDS Alliance in Ukraine, Kyiv, Ukraine.
Samuel R Friedman
Jose Lourenco
Sunetra Gupta
Angelos Hatzakis
Oliver G Pybus
Aris Katzourakis
Pavlo Smyrnov
Timokratis Karamitros
Dimitrios Paraskevis
Gkikas Magiorkinis
University of Oxford · GBCreative Commons · USNational Development and Research Institutes · US

Funding

Preventing HIV Transmission by Recently-Infected Drug UsersDP1DA034989 · NIDA · NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC. · PI FRIEDMAN, SAMUEL R · 2012 to 2016
$3.8M
Medical Research Council MR/K010565/1NIDA NIH HHS DP1 DA034989
6 · The paper itself

Abstract

objectiveAlthough our understanding of viral transmission among people who inject drugs (PWID) has improved, we still know little about when and how many times each injector transmits HIV throughout the duration of infection. We describe HIV dynamics in PWID to evaluate which preventive strategies can be efficient.

designDue to the notably scarce interventions, HIV-1 spread explosively in Russia and Ukraine in 1990s. By studying this epidemic between 1995 and 2005, we characterized naturally occurring transmission dynamics of HIV among PWID.

methodWe combined publicly available HIV pol and env sequences with prevalence estimates from Russia and Ukraine under an evolutionary epidemiology framework to characterize HIV transmissibility between PWID. We then constructed compartmental models to simulate HIV spread among PWID.

resultsIn the absence of interventions, each injector transmits on average to 10 others. Half of the transmissions take place within 1 month after primary infection, suggesting that the epidemic will expand even after blocking all the post-first month transmissions. Primary prevention can realistically target the first month of infection, and we show that it is very efficient to control the spread of HIV-1 in PWID. Treating acutely infected on top of primary prevention is notably effective.

conclusionAs a large proportion of transmissions among PWID occur within 1 month after infection, reducing and delaying transmissions through scale-up of harm reduction programmes should always form the backbone of HIV control strategies in PWID. Growing PWID populations in the developing world, where primary prevention is scarce, constitutes a public health time bomb.

Indexed as

Disease Transmission, Infectiousenv Gene Products, Human Immunodeficiency VirusHarm ReductionHIVHIV InfectionsHumansMolecular Epidemiologypol Gene Products, Human Immunodeficiency VirusPrevalencePrimary PreventionRussiaSequence Analysis, DNASubstance Abuse, IntravenousUkraineenv Gene Products, Human Immunodeficiency Viruspol Gene Products, Human Immunodeficiency Virus

Identifiers

PMID27824626
PMCPMC5106086
OpenAlexW2550805067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.